Acetaminophen, Caffeine and Dihydrocodeine Bitartrate (Larken Laboratories Inc.)
Welcome to the PulseAid listing for the Acetaminophen, Caffeine and Dihydrocodeine Bitartrate drug offered from Larken Laboratories Inc.. This Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient],Full Opioid Agonists [MoA],Opioid Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Larken Laboratories Inc. |
| NON-PROPRIETARY NAME: | Acetaminophen, Caffeine and Dihydrocodeine Bitartrate |
| SUBSTANCE NAME: | ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient],Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-10-04 |
| END MARKETING DATE: | 0000-00-00 |
Acetaminophen, Caffeine and Dihydrocodeine Bitartrate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Acetaminophen, Caffeine and Dihydrocodeine Bitartrate from Larken Laboratories Inc. |
| LABELER NAME: | Larken Laboratories Inc. |
| DEA SCHEDULE: | CIII
|
| ACTIVE STRENGTH: | 325; 30; 16(mg/1; mg/1; mg/1) |
| START MARKETING DATE: | 2016-10-04 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68047-720_5ae54790-fd03-28f4-e053-2a91aa0a05c5 |
| PRODUCT NDC: | 68047-720 |
| APPLICATION NUMBER: | ANDA204209 |
Other ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE Pharmaceutical Manufacturers / Labelers:
